Monday, December 23, 2024
HomeTagsPost-COVID Syndrome

Post-COVID Syndrome

StemCyte Announces FDA Approval of IND for a Phase II Clinical Trial

Southern California cord blood regenerative therapeutics company StemCyte is pleased to announce it has received approval from the U.S. Food and Drug Administration (FDA)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics